stock price
Mainz Biomed Stock Spikes on Positive Data for mRNA-Enhanced Colorectal Cancer Screening Assay
In top-line data, Mainz Biomed's enhanced ColoAlert detected CRC with 94 percent sensitivity and 97 percent specificity, and advanced adenoma with 81 percent sensitivity.
Natera Launches $250M Follow-On Stock Offering at $55 Per Share
Natera is offering 4,550,000 common shares at $55 per share in the offering, which is expected to close Sept. 11, with additional shares available to the underwriters.
Shareholder Calls on Cue Health to Begin Strategic Review, Realign Costs
The shareholder, Tarsadia Investments, noted concerns about Cue's cost structure and future business plans.
Aspira's Stock Plummets on New $4.7M Registered Direct Offering
Shares were down as much as 34 percent after the company announced the registered direct offering of 1,694,820 shares of common stock.
Accelerate Diagnostics Stock Drops 23 Percent on Restructuring, Debt Transactions
The company's shares closed at $.79 per share on Tuesday after Accelerate announced it has closed transactions related to its restructuring support agreement.
May 5, 2023
Trinity Biotech Regains Nasdaq Compliance
May 1, 2023
360Dx Top 30 Slides 2 Percent in April
Sep 1, 2022
360Dx Top 30 Tumbles in August
Apr 1, 2022
360Dx Top 30 Falls Slightly in March
Feb 1, 2022
360Dx Top 30 Plummets 17 Percent in January
Jan 4, 2022